Market Access France ‘first EU country to cover obesity drugs’ PharmaphorumFrance's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.Metabolic & GLP-1Read full story pharminent May 28, 2026 (Last updated: May 29, 2026) Pharmaphorum France’s Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: GSK hails ‘unprecedented’ cure rates with hep B drugNext: CVS obesity drug deal puts Lilly on equal footing with Novo Related Stories Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026 Market Access UK, pharma industry pilot rapid access routes for medicines pharminent July 5, 2026 Market Access Medicare GLP-1 Bridge Launches July 1 With $50 Copays pharminent July 3, 2026
